Eloctate is a self-adminstered injection for people who deal with chronic joint bleeds as a result of hemophilia. When used once a week, Eloctate can resolve up to 99.6% of bleeds, with many patients have 0 per year. This DTC campaign spread awareness through digital storytelling and science-backed claims.
Full length TV spot
Animated social media featuring call to action asking viewers to define who their "Hemrock" (Hemophilic rockstar) is.
Social media GIF featuring simplified dosing RTB
This integrated package design was a concept for new patients to help them on their treatment journey. It features a portable rechargeable refrigerant capsule so you can take your dose with you when needed.
Our final conceptual push was to partner with Sanofi's AI program, HemAssist, to offer patients a fun, friendly alternative to computer speak. Since this campaign specifically targeted joint bleeds, we created a conversation with an ankle to sell the idea in.
Creative direction: Mike Woods
Art: David Harris
Copy: Jillian Aramowicz
Agency: FCB Health Chicago
Art: David Harris
Copy: Jillian Aramowicz
Agency: FCB Health Chicago